Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia
1 other identifier
observational
250
1 country
2
Brief Summary
COVID-19 has adversely affected the healthcare system across the world. The world was not prepared for global outbreak of infectious diseases. The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is enabling researchers worldwide to acquire a large amount of clinical data regarding coronavirus disease (COVID-19). The COVID-19 infection severely affects the respiratory system in the critical cases and results in mortalities. The affected people experience a dry cough, fever, breathing problems, diarrhea, muscle pain, and sore throat. Besides that, some of the evidence from Italy, South Korea, China, and Spain suggest that the COVID-19 cases also lose their senses of smell and taste resulting in alterations in those patients. The objective of this proposed study is to determine whether COVID-19 cases have Olfactory and gustatory dysfunctions as a hallmark indicator and can be used as diagnostic tools for the isolation of suspected people. Investigators are presenting a prospective proportional case-control study that is conducted to investigate the COVID-19 cases with anosmia and /or Ageusia in a university hospital in Riyadh, Saudi Arabia. The sample size of this case series would be 250 cases of suspected COVID-19 patients. The cases included in the study are analyzed prospectively to determine if the cases had a history of anosmia and /or Ageusia, and then tested for the alteration of these senses through a panel of standardized odors/taste strips. That is looked at statistically allowing us to confirm the proposed effectiveness of these tests as a diagnostic tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2020
CompletedFirst Posted
Study publicly available on registry
May 14, 2020
CompletedStudy Start
First participant enrolled
June 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedMay 4, 2022
May 1, 2022
1.5 years
May 13, 2020
May 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
correlation of anosmia and ageusia to covid19 positive patients
to how extent alteration of smell and taste senses is related to covid19 status
from 1/06/2020 to 31/12/2020
Secondary Outcomes (1)
objective assessment of severity of smell and taste senses alterations in covid19 patients
from 1/06/2020 to 31/12/2020
Study Arms (2)
covid19 positive patients
participants who present with signs and symptoms suspected for covid19 and swabbed/tested positive
covid19 negative patients
participants who present with signs and symptoms suspected for covid19 and swabbed/tested negative
Interventions
participants will be asked to smell 8 cards of different odors and submit your choices in a given card, and so for 3 different taste tips (salty, bitter and neutral). participants will be asked to submit his choices in a given card as well. Then participants photograph those cards and send it via WhatsApp to a given number to be collected
Eligibility Criteria
Upon identification of the patient in the triage area the research assistant will start the study by introducing the concept for the patient and then taking consent. The patient will go through the regular flow of patients in the ED and after being asked to do the swabs the research assistant will start the process of the study by testing the smell by the NHANES cards then directly assess the taste by the NHANES strips and documents the results on the cards
You may qualify if:
- Suspected cases of COVID -19 fulfilling the case definition of Saudi CDC 2- Adult patients
You may not qualify if:
- The cases of children under the age of 12 years
- Known patients with Kallmann's syndrome, CHARGE syndrome, Indifference to pain syndrome, ciliopathy disorders.
- Known patient with congenital anomalies, absent smell sense, and absent taste sense.
- Pregnant and lactating ladies
- Patients with trigeminal nerve disease
- Blind and deaf patients
- Malingering.
- Adults aged more than 65 years old.
- Allergy to quinine products
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Princess Nourah Bint Abdulrahman Univeristy
Riyadh, Central, 11552, Saudi Arabia
prince Mohammed bin Abdulaziz Hospital
Riyadh, Central, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
OSAMA KENTAB, M.D
Princess Nourah Bint Abdulrahman University
- STUDY DIRECTOR
AHMAD AALIBRAHIM, M.D
Princess Nourah Bint Abdulrahman University
- STUDY CHAIR
MARZOOQA ALENIZI, M.D
Princess Nourah Bint Abdulrahman University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- m.d, FAAP, FACEP , CLINICAL ASSOCIATE PROFESSOR OF EMERGENCY MEDICINE, SENIOR CONSULTANT PEDIATRIC EMERGENCY MEDICINE
Study Record Dates
First Submitted
May 13, 2020
First Posted
May 14, 2020
Study Start
June 15, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
May 4, 2022
Record last verified: 2022-05